The fall in real terms essentially reflects the institutionalisation of price reductions across a medicine's lifecycle and the fact the forecast does not make allowances for new listings.
The PBS shows declining spend, as it now almost always will
March 29, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
How education exposes the moral and ethical limits of our health decision-making
August 11, 2026 - - Latest News -
Percheron turns to former Arovella chief Michael Baker for next phase of HMBD 002 development
August 10, 2026 - - Latest News -
Australian company points to encouraging survival signal in mesothelioma CAR-T study
August 10, 2026 - - Australian Biotech -
GBMA White Paper calls for reforms to strengthen supply chain resilience
August 10, 2026 - - Latest News -
Achieving value is meaningless if it undermines access to medicines
August 10, 2026 - - Latest News -
New Zealand's ACT announces plan for pharmacies to do a lot more, but also ownership and location reform
August 10, 2026 - - Latest News -
France the first to provide comprehensive reimbursement for GLP-1s for weight loss while Australia looks on
August 10, 2026 - - Latest News

